Advertisement

Topics

Anti-Cancer Institute Company Profile

07:23 EDT 22nd June 2018 | BioPortfolio


News Articles [4298 Associated News Articles listed on BioPortfolio]

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association...

Daffodils to fight cancer: Anti-cancer effect of a daffodil extract

A research describes the anti-cancer effects of a natural alkaloid extracted from daffodils. The researchers have discovered that this compound triggers the activation of an anti-tumoral surveillance ...

Huntsman Cancer Institute CEO and Director honored by National Cancer Institute

(University of Utah Health) Mary Beckerle, PhD, CEO and Director of Huntsman Cancer Institute (HCI) at the University of Utah, is this year's recipient of the Alfred G. Knudson Award in Cancer Genetic...

TGen-led study finds potent anti-cancer drug effect in rare ovarian cancer

(The Translational Genomics Research Institute) An anti-cancer drug used to fight leukemia shows promise against a rare and aggressive type of ovarian cancer -- small cell carcinoma of the ovary hyper...

Black patients show stronger response to hormone therapy for prostate cancer

(Duke University Medical Center) African-American men with advanced prostate cancer might be more responsive than white men to an anti-androgen drug and steroids, according to a study led by Duke Canc...

African-American men with prostate cancer show stronger response to hormone therapy

African-American men with advanced prostate cancer might be more responsive than white men to an anti-androgen drug and steroids, according to a study led by Duke Cancer Institute researchers.

Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis

(Wyss Institute for Biologically Inspired Engineering at Harvard) The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering a...

Molecular 'magnets' could improve cancer immunotherapy

(The Francis Crick Institute) Chemicals that attract specialised immune cells toward tumours could be used to develop better immunotherapies for cancer patients, according to new research published in...

Drugs and Medications [567 Associated Drugs and Medications listed on BioPortfolio]

Halaven [Eisai Inc.]

These highlights do not include all the information needed to use HALAVEN™ safely and effectively. See full prescribing information for HALAVEN. HALAVEN™ (eribulin mesylate) Injection For intraven...

Oral-b neutra-foam mint [Oral-B Laboratories]

Package. Label Principal Display Panel

Ck one waterfresh face makeup spf 15 [Coty US LLC]

Drug Facts

Ck one waterfresh face makeup spf 15 [Coty US LLC]

Drug Facts

Ck one waterfresh face makeup spf 15 [Coty US LLC]

Drug Facts

PubMed Articles [8452 Associated PubMed Articles listed on BioPortfolio]

US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer.

Since 2007, the US National Cancer Institute (NCI) Office of Cancer Complementary and Alternative Medicine (OCCAM), together with the Cancer Institute of the China Academy of Chinese Medical Sciences ...

In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?

The advent of anti-programmed death receptor-1/ligand-1 antibodies (anti-PD(L)1) is profoundly changing the therapeutic strategy of oncology. As anti-PD(L)1 modulate tumour microenvironment, it might ...

Updates to the National Cancer Institute's PDQ Information from Recently Published Oncology Research.

Culturally Competent Care for Sexual and Gender Minority Patients at National Cancer Institute-Designated Comprehensive Cancer Centers.

This study sought to identify the policies and guidelines regarding culturally competent care of sexual and gender minority (SGM) cancer patients and survivors at National Cancer Institute (NCI)-Desig...

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.

ALK, ROS1, and NTRK fusions occur in 0.2% to 2.4% of colorectal cancers. Pioneer cases of metastatic colorectal cancer (mCRC) patients bearing rearrangements who benefited from anti-ALK, ROS, and TrkA...

Clinical Trials [11388 Associated Clinical Trials listed on BioPortfolio]

Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience

The goal of this study is to evaluate the Salah Azaïz Cancer Institute male breast cancer patients population over a period of 14 years. Goal of the retrospective part: to gather clinico...

Bergonie Institute Breast Cancer Database

A database of breast cancer patients was established at Institute Bergonié since the 90s , to assess patients' survival, assess practice, search for prognostic factors.

Cancer in Infants: South Egypt Cancer Institute Experience

The aim of this study is to investigate the spectrum of various types of malignant neoplasms of infancy, according to the experience of South Egypt Cancer Institute, which represents the l...

Addressing Prostate Cancer Information Disparities With eHealth Technology

his is a multicenter study that involves research on screening for prostate cancer. This study pilot tests a culturally appropriate decision aid (DA) for African American (AA) men that wil...

Promoting Quality of Life Among Young Adult Cancer Survivors

This study expands on a prior pilot study to refine the intervention messaging to focus on goal-oriented thinking, include a coach, and extend the intervention to a larger sample of young ...

Companies [2935 Associated Companies listed on BioPortfolio]

Anti-Cancer Institute

The Barbara Ann Karmanos Cancer Institute

Located in mid-town Detroit, Michigan, the Barbara Ann Karmanos Cancer Institute is one of 40 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for nearl...

Ovarian Cancer Institute

The Ovarian Cancer Institute is a 501(c)(3) organization dedicated to ovarian cancer research. The work focuses on accurate diagnostics and improved therapeutics. Creators of a fi...

The North Shore-LIJ Cancer Institute

The North Shore-LIJ Cancer Institute is one of the largest cancer providers in the New York metropolitan area. With 200 physicians, the Cancer Institute diagnoses and/or treats mo...

Synergys Biotherapeutics

Synergys is an early stage company developing multifunctional anti-vascularization antibody drugs targeting VEGF-alternative pathways. The Company’s most advanced product can...

More Information about "Anti-Cancer Institute" on BioPortfolio

We have published hundreds of Anti-Cancer Institute news stories on BioPortfolio along with dozens of Anti-Cancer Institute Clinical Trials and PubMed Articles about Anti-Cancer Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Anti-Cancer Institute Companies in our database. You can also find out about relevant Anti-Cancer Institute Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record